Isoquinolinamine and phthalazinamine derivatives: corticotropin-

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514310, A61K 3147, C07D21722

Patent

active

061145300

ABSTRACT:
Disclosed are compounds that are highly selective partial agonists or antagonists at human CRF.sub.1 receptors that are useful in the diagnosis and treatment of treating stress related disorders such as post traumatic stress disorder (PTSD) as well as depression, headache and anxiety. The compounds have the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein Ar, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and W are various organic and inorganic substituents.

REFERENCES:
patent: 3274185 (1966-09-01), Sigal et al.
patent: 3753988 (1973-08-01), Rodway et al.
patent: 4956371 (1990-09-01), Shoupe
Sindler-Kulyk, M. et al., "Photocycloaddition Reactions of 3-Phenyl-1,2-benzisothiazole and Alkynes", Journal of Org. Chem., vol. 48 No. 8, 1983, pp. 1275-1281.
Holava, H. M. Jr. et al., "1-Substituted 4-Aryl- (or 4-Aralkyl-) phthalazines", New Compounds, vol. 12, 1969, pp. 555-556.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Isoquinolinamine and phthalazinamine derivatives: corticotropin- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoquinolinamine and phthalazinamine derivatives: corticotropin-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinolinamine and phthalazinamine derivatives: corticotropin- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2213513

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.